[144] Sera Prognostics, Inc. SEC Filing
Rhea-AI Filing Summary
Sera Prognostics submitted a Form 144 notice proposing the sale of 5,962 Class A common shares, with an aggregate market value of $15,145. The filing reports 38,061,868 shares outstanding, placing the proposed sale in the context of the company's issued share base.
The shares are scheduled for sale on 08/08/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The securities were acquired by Restricted Stock Unit vesting from the issuer on 08/08/2025, with payment noted as not applicable.
The filing also discloses prior sales by Robert Harrison: 6,551 shares on 05/08/2025 for $16,001 and 667 shares on 06/10/2025 for $990. The signer represents no knowledge of undisclosed material adverse information.
Positive
- Compliance disclosure: The filing is a formal Form 144 notice, indicating an effort to comply with Rule 144 requirements.
- Clear transaction details: Specifies 5,962 shares, $15,145 aggregate market value, broker (Morgan Stanley Smith Barney), and sale date (08/08/2025).
- Acquisition source disclosed: Securities were acquired via Restricted Stock Unit vesting, clarifying the origin of the shares.
Negative
- None.
Insights
TL;DR: Routine Rule 144 notice for a small number of shares; likely immaterial to market price given size.
The filing documents a proposed sale of 5,962 Class A shares with an aggregate market value of $15,145 and notes 38,061,868 shares outstanding. That scale suggests the transaction is administratively important for the seller but unlikely to be market-moving by itself. The use of a major broker (Morgan Stanley Smith Barney) and disclosure of acquisition via RSU vesting clarifies transfer mechanics and compliance with Rule 144.
TL;DR: Disclosure follows required Rule 144 procedures and includes seller representation about material nonpublic information.
The notice reports the source of shares as RSU vesting on the same date as the proposed sale and includes the standard representation that the seller is not aware of undisclosed material adverse information. The filing also lists prior dispositions by an identified seller, demonstrating recent trading activity disclosure. From a governance standpoint, the form meets routine disclosure expectations contained in Rule 144 filings.